Stock News Buzz: Dorchester Minerals, L.P. (NASDAQ:DMLP)

Dorchester Minerals, L.P. (NASDAQ:DMLP) changed 0.32% to recent value of $9.38. The stock transacted 44213 shares during most recent day however it has an average volume of 128.43K shares. It spotted trading -56.29% off 52-week high price. On the other end, the stock has been noted 10.09% away from the low price over the last 52-weeks.

On April 3, 2020, Dorchester Minerals, L.P. (NASDAQ:DMLP) released that, due to the emerging public health impact of the COVID-19 (Coronavirus) pandemic, the date, time and location and format of its 2020 Annual Meeting of Limited Partners (the 2020 Annual Meeting) has been changed to 2:00 p.m. Central Time on Monday, May 18, 2020, and from an in-person meeting to a virtual meeting. Unitholders may not attend the meeting in person.

On April 2, 2020, the Partnership’s Board of Managers (the Board) approved the change to the date, time, location and format of the 2020 Annual Meeting in support of the health and well-being of the Partnership’s employees, unitholders and other associates, as well as the related protocols that have been or may be imposed by federal, state and local governments.

Unitholders of record at the close of business on March 19, 2020 will be able to access the 2020 Annual Meeting webcast at www.virtualshareholdermeeting.com/DMLP2020. Unitholders who attend the virtual meeting with their 16-digit control number as identified on their proxy card or their voting instruction form, will have the same rights and opportunities to participate as they would at an in-person meeting. Unitholders issued a voting instruction form that does not contain a 16-digit control number will still be able to attend the 2020 Annual Meeting as a guest and listen to the proceedings but must contact their brokerage firm, bank, or other financial institution for instructions on how to vote at the 2020 Annual Meeting. All Unitholders may continue to cast their votes for the 2020 Annual Meeting at www.proxyvote.com until 11:59 p.m. Eastern Time the day before the cut-off date or meeting date and in accordance with the instructions in the Partnership’s proxy materials. Registered Unitholders may also submit questions for the 2020 Annual Meeting at [email protected] until 11:59 p.m. Eastern Time five days prior to the date of the 2020 Annual Meeting.

DMLP has a gross margin of 91.60% and an operating margin of 67.00% while its profit margin remained 64.80% for the last 12 months. Its earnings per share (EPS) expected to touch remained -7.10% for this year.

The company has 35.97M of outstanding shares and 31.55M shares were floated in the market. According to the most recent quarter its current ratio was 12 that represents company’s ability to meet its current financial obligations. The price moved ahead of -9.69% from the mean of 20 days, -31.86% from mean of 50 days SMA and performed -45.45% from mean of 200 days price. Company’s performance for the week was 3.19%, -32.95% for month and YTD performance remained -51.92%.

Notable News to Focus: Jazz Pharmaceuticals plc (NASDAQ:JAZZ)

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) stock observed trading -35.33% off 52-week high price. On the other end, the stock has been noted 14.80% away from low price over the last 52-weeks. The stock disclosed a move of -20.78% away from 50 day moving average and -25.25% away from 200 day moving average. Moving closer, we can see that shares have been trading -5.91% off 20-day moving average. It has market cap of $5.82B.

On March 31, 2020, Jazz Pharmaceuticals plc (NASDAQ:JAZZ) provided an update regarding the impact of COVID-19 on its business and the actions it is taking to mitigate the spread of this virus.

Jazz provides essential medicines to patients around the world and we are committed to delivering on this important mission.  We have implemented a robust continuity plan to address the impact of COVID-19 on our business.  We are highly focused on ensuring patients have access to our medicines and protecting the health and safety of our employees and the communities in which we operate, said Bruce Cozadd, chairman and chief executive officer of Jazz Pharmaceuticals.  The company is in a strong financial position, having entered the year with over $1 billion in cash and investments and access to significant additional liquidity.  Our financial strength prepares us to navigate through this pandemic while continuing to execute on our key strategic objectives to support our long-term growth.

Jazz sees a limited financial impact, given its portfolio of differentiated products addressing chronic and life-threatening diseases. However, given the global economic slowdown, reduced field-based interactions with healthcare professionals and the uncertainty surrounding the scale and duration of the pandemic, the company, at this time, cannot rule out future impact on its business and associated guidance.  Jazz expects to provide an update on all key business areas during its first quarter 2020 financial results in early May.

The Ireland based company Jazz Pharmaceuticals plc moved with change of 0.14% to $99.74 with the total traded volume of 709472 shares in recent session versus to an average volume of 679.93K shares. The stock was observed in the 5 days activity at 4.31%. The one month performance of stock was -20.28%. JAZZ’s shares are at -32.90% for the quarter and driving a -30.22% return over the course of the past year and is now at -33.19% since this point in 2018.  Right now the stock beta is 1.29. The average volatility for the week and month was at 5.29% and 8.23% respectively. There are 58.32M shares outstanding and 54.56M shares are floated in market.

Eye Catching Stock News: Recon Technology, Ltd. (NASDAQ:RCON)

Recon Technology, Ltd. (NASDAQ:RCON) stock identified change of 40.54% away from 52-week low price and recently located move of -70.57% off 52-week high price. It has market worth of $5.44MM. RCON stock has been recorded -28.56% away from 50 day moving average and -51.21% away from 200 day moving average. Moving closer, we can see that shares have been trading -22.86% off 20-day moving average.

On March 23,2020, Recon Technology, Ltd. (NASDAQ:RCON) released the operation result of DT Refuel mobile application (DT Refuel), which is developed by the Company’s subsidiary Future Gas Station (Beijing) Technology, Ltd (FGS). The single-day Gross Merchandise Value (GMV) of DT Refuel has hit a new high of $2.19 million (RMB15.32 million) on March 18, 2020.

DT Refuel acts as an e-commerce platform aiming at improving the refueling experience of car owners. It allows users to buy oil products and groceries and pay the fuel through their phones. It also provides navigation and enables users to query traffic violation through the application to make their daily lives easier.

As of March 19, 2020, DT Refuel has a total of 3.76 million registered users. Among them, 3 million users have paid refueling through the application at least once, and 1.46 million users have paid refueling through the application more than once.

From January 1 to March 19, 2020, DT Refuel’s total GMV was $57.18 million (RMB400.3 million), approximately equaling its total GMV of the first half in 2019. Its total GMV increased $19.68 million (RMB137.79 million) or 257.44% to $27.33 million (RMB191.31 million) year-over-year in January 2020 from January 2019. Its total GMV increased $3.58 million (RMB22.08 million) or 65.26% to $9.07 million (RMB63.5 million) year-over-year in February 2020 from February 2019. From March 1 to March 19, 2020, its total GMV was $20.78 million (RMB145.49 million), already 175% more than the total GMV in March 2019.

The Basic Materials sector company, Recon Technology, Ltd. noticed change of 3.31% to $1.56 along volume of 211 shares in recent session compared to an average volume of 60.34K. The stock observed return of -8.77% in 5 days trading activity. The stock was at -25.00% over one month performance. RCON’s shares are at -51.85% for the quarter and driving a -68.48% return over the course of the past year and is now at -32.17% since this point in 2018.

The average volatility for the week at 21.89% and for month was at 18.06%. There are 3.49M shares outstanding and 2.63M shares are floated in market. Right now the stock beta is 2.02.

Stock News in Focus: Ideanomics (NASDAQ:IDEX)

Ideanomics (NASDAQ:IDEX) stock observed trading -80.63% off 52-week high price. On the other end, the stock has been noted 99.28% away from low price over the last 52-weeks. The stock disclosed a move of 4.62% away from 50 day moving average and -55.41% away from 200 day moving average. Moving closer, we can see that shares have been trading 44.22% off 20-day moving average. It has market cap of $68.32M.

On March 23,2020, Ideanomics (NASDAQ:IDEX) is pleased to announce a strategic framework agreement with leading EV heavy truck and bus manufacturer, BeiBen Heavy Truck Co. Ltd (BeiBen). The framework agreement is designed to establish a long-term strategic partnership that will create a strategic platform to increase the speed and efficiency of commercial vehicle adoption. The framework agreement is preliminary in nature and its implementation will be subject to legally binding definitive transaction documents to be negotiated and entered into between Ideanomics and BeiBen.

Under the agreement, BeiBen will provide electric heavy truck manufacturing, research and development, sales, operations, and other resources. MEG will provide its existing new energy vehicle platform including its financial services network, marketing capabilities, government relationships, and partners upstream and downstream including in Southeast Asia.

The USA based company Ideanomics moved with change of -1.87% to $0.55 with the total traded volume of 2490604 shares in recent session versus to an average volume of 810.18K. The stock was observed in the 5 days activity at 46.55%. The one month performance of stock was 8.16%. IDEX’s shares are at -27.19% for the quarter and driving a -69.44% return over the course of the past year and is now at -35.73% since this point in 2018.  Right now the stock beta is 2. The average volatility for the week and month was at 56.82% and 26.14% respectively. There are 124.22M shares outstanding and 111.88M shares are floated in market.

Stock News in Focus: Thor Industries (NYSE:THO)

Thor Industries (NYSE:THO) changed -3.23% to recent value of $35.99. The stock transacted 1813851 shares during most recent day however it has an average volume of 936.02K shares. It spotted trading -59.77% off 52-week high price. On the other end, the stock has been noted 11.09% away from the low price over the last 52-weeks.

On March 19,2020, Thor Industries (NYSE:THO) declared that its Board of Directors approved, at their March 19, 2020 meeting, the payment of a regular quarterly cash dividend of $0.40 per share.

The regular cash dividend is payable on April 16, 2020, to shareholders of record at the close of business on April 2, 2020.

About Thor Industries

Thor is the sole owner of operating subsidiaries that, combined, represent the world’s largest manufacturer of recreational vehicles.

THO has a gross margin of 13.20% and an operating margin of 2.80% while its profit margin remained 2.30% for the last 12 months. Its earnings per share (EPS) expected to touch remained -71.40% for this year while earning per share for the next 5-years is expected to reach at 3.60%.

The company has 55.20M of outstanding shares and 52.95M shares were floated in the market. According to the most recent quarter its current ratio was 1.4 that represents company’s ability to meet its current financial obligations. The price moved ahead of -42.87% from the mean of 20 days, -51.30% from mean of 50 days SMA and performed -42.32% from mean of 200 days price. Company’s performance for the week was -27.83%, -59.14% for month and YTD performance remained -51.55%.

News to Track: Armata Pharmaceuticals (NYSE:ARMP)

Armata Pharmaceuticals (NYSE:ARMP) stock identified change of 12.24% away from 52-week low price and recently located move of -60.26% off 52-week high price. It has market worth of $32.09MM. ARMP stock has been recorded -22.11% away from 50 day moving average and -27.11% away from 200 day moving average. Moving closer, we can see that shares have been trading -21.92% off 20-day moving average.

On March 19,2020, Armata Pharmaceuticals (NYSE American:ARMP) a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections,  released results for the fourth quarter and full year 2019 and provided a corporate and clinical update.

Key Fourth Quarter and Subsequent Period Highlights:

  • Entered into a $25 million securities purchase agreement pursuant to which Innoviva (Innoviva) will purchase approximately 8.7 million shares of Armata common stock at $2.87 per share and warrants to purchase an additional approximately 8.7 million shares with an exercise price of $2.87 per share.
  • Announced the closing of the first tranche of the Innoviva securities purchase agreement, issuing 993,139 common shares and warrants to purchase 993,139 common shares in exchange for gross proceeds of approximately $2.8 million. The Company obtained voting agreements from shareholders representing approximately 55% of its outstanding shares that have agreed to vote in favor of the financing at the special shareholder meeting now scheduled for March 26, 2020. Following approval at the meeting, the second tranche of $22.2 million will be received by Armata.
  • In connection with the financing transaction, appointed Sarah Schlesinger, M.D. and Odysseas Kostas, M.D. to its Board of Directors, both of whom also serve on the Board of Innoviva.
  • Continued to advance development of its lead program, a Pseudomonas aeruginosa phage product candidate AP-PA02, toward submission of an Investigational New Drug application (IND) seeking regulatory approval to initiate a first-in-human clinical trial this year. GMP production of the product candidate has been completed at the Company’s Marina del Rey facility.
  • Announced that the Company has been awarded up to $5 million in a development award grant from the Cystic Fibrosis Foundation to help fund the Pseudomonas aeruginosa phage development.
  • Expanded the Board of Directors with the appointment of research and development veteran Todd C. Peterson, Ph.D., and strengthened its clinical team with the appointment of Heather Dale Jones, M.D., as Vice President, Clinical Development.

The stock observed return of -8.33% in 5 days trading activity. The stock was at -38.20% over one month performance. ARMP’s shares are at -33.25% for the quarter and driving a -38.62% return over the course of the past year and is now at -15.38% since this point in 2018.

The average volatility for the week at 15.06% and for month was at 10.29%. There are 11.67M shares outstanding and 6.84M shares are floated in market. Right now the stock beta is 2.14.

Notable News to Focus: CHF Solutions (NASDAQ:CHFS)

CHF Solutions (NASDAQ:CHFS) stock observed trading -93.46% off 52-week high price. On the other end, the stock has been noted 6.63% away from low price over the last 52-weeks. The stock disclosed a move of -41.22% away from 50 day moving average and -79.53% away from 200 day moving average. Moving closer, we can see that shares have been trading -22.04% off 20-day moving average. It has market cap of $5.46M.

On March 20, 2020, CHF Solutions (NASDAQ:CHFS) notified the pricing of a registered direct offering of 4,161,392 shares of its common stock at a price to the public of $0.30 per share, for gross proceeds of approximately $1,248,000, prior to deduction of commissions and offering expenses payable by CHF Solutions. In a concurrent private placement, the Company agreed to issue to the investors in the registered direct offering unregistered warrants to purchase up to 4,161,392 shares of the Company’s common stock.

Ladenburg Thalmann & Co. Inc. is acting as exclusive placement agent in connection with the offering.

The Company intends to use the net proceeds for the offering for general corporate purposes, including the continued investment in commercialization efforts.

The warrants to purchase up to 4,161,392 shares of common stock have an exercise price of $0.3726 per share, will be exercisable six months from the date of issuance, and will expire five and a half years from the date of issuance. The Company has agreed to file a registration statement registering the shares of common stock issuable upon exercise of the warrants within sixty days of the closing of the private placement.

The USA based company CHF Solutions moved with change of -14.14% to $0.32 with the total traded volume of 3434694 shares in recent session versus to an average volume of 2.88M shares. The stock was observed in the 5 days activity at -17.97%. The one month performance of stock was -14.65%. CHFS’s shares are at -56.77% for the quarter and driving a -91.65% return over the course of the past year and is now at -62.85% since this point in 2018.  Right now the stock beta is 2.03. The average volatility for the week and month was at 32.82% and 25.44% respectively. There are 17.06M shares outstanding.

Notable News Spotlight: Domo (NASDAQ:DOMO)

Domo (NASDAQ:DOMO) changed 10.33% to recent value of $12.71. The stock transacted 742178 shares during most recent day however it has an average volume of 508.26K shares. It spotted trading -73.00% off 52-week high price. On the other end, the stock has been noted 24.00% away from the low price over the last 52-weeks.

On March 12, 2020, Domo (NASDAQ:DOMO) reported it has been named on the Women Tech Council (WTC) 2020 Shatter List, a recognition of companies with active measures that help break the glass ceiling for women in technology. This is Domo’s third consecutive Shatter List inclusion, with each of the companies on the 2020 list chosen based on their development and successful implementation of measures that create gender-inclusive cultures where women can contribute and succeed.

The Shatter List is designed to measure the policies, practices and organizations that are creating real impact for women in tech, said Cydni Tetro, president of WTC. These organization-wide, holistic solutions to actively create gender-inclusive environments and teams make impact not only for those within an organization, but throughout the technology community by helping advance women across the entire sector.

The Shatter List was developed as part of WTC’s diversity and inclusion program and commitment to help build high-performing environments where men and women can succeed and drive company success. To make the Shatter List, Domo was evaluated and scored against hundreds of technology companies on four key criteria: executive engagement, company programming, community investment and women’s or D&I groups. Each named company was required to demonstrate active, visible activities at all company levels showing commitment and progress in these four areas.

DOMO has a gross margin of 67.70% and an operating margin of -68.70% while its profit margin remained -74.50% for the last 12 months. Its earnings per share (EPS) expected to touch remained 18.30% for this year.

The company has 29.73M of outstanding shares and 23.36M shares were floated in the market. According to the most recent quarter its current ratio was 1.3 that represents company’s ability to meet its current financial obligations. The price moved ahead of -39.53% from the mean of 20 days, -44.40% from mean of 50 days SMA and performed -44.11% from mean of 200 days price. Company’s performance for the week was -28.47%, -48.35% for month and YTD performance remained -41.48%.

Stock News Alert: Full House Resorts (NASDAQ:FLL)

Full House Resorts (NASDAQ:FLL)  stock observed trading -72.68% off 52-week high price. On the other end, the stock has been noted 12.61% away from low price over the last 52-weeks. The stock disclosed a move of -64.42% away from 50 day moving average and -56.76% away from 200 day moving average. Moving closer, we can see that shares have been trading -61.07% off 20-day moving average. It has market cap of $47.68M.

On March 12, 2020, Full House Resorts (NASDAQ:FLL) declared results for the fourth quarter ended December 31, 2019.

Coronavirus

The Company is carefully monitoring the coronavirus situation. As of, it knows of no confirmed cases of the virus at any of its properties. Nevertheless, it has implemented additional cleaning and disinfection procedures at each of its properties. Beginning yesterday, for the protection of its employees and customers, the Company* began testing employee temperatures with infrared monitors as they arrive for work. Any employee registering greater than 100°F is told to return home and to contact his or her usual health care provider. Yesterday, the first day of the screening procedures, the Company had zero employees reporting for work registering such a fever.

The Company is carefully monitoring the situation and will, of course, cooperate with all local health and regulatory agencies. Although this may change, to date our business activity has shown no discernible impact from either the virus or the stock market. Note that our casinos have negligible meeting and convention business and that few of our customers travel by air to visit us. Furthermore, as online sports wagering continues to ramp up over the next few months, it should contribute a significant portion of the Company’s income.

Fourth Quarter and Full Year

On a consolidated basis, net revenues in the fourth quarter of 2019 decreased 4.1% to $39.0 million from $40.7 million in the prior-year period.  Net loss for the fourth quarter of 2019 was $4.1 million, or $(0.15) per diluted common share, compared to a net loss of $1.0 million, or $(0.07) per diluted common share, in the prior-year period.  Net loss in both periods was affected by the accounting for the fair market value of outstanding warrants.  Adjusted EBITDA(a) in the 2019 fourth quarter was $2.3 million versus $3.8 million in the fourth quarter of 2018, reflecting casino downtime during the installation of new slot systems at Bronco Billy’s and Rising Star, as well as a temporary increase in marketing expenses at Rising Star.  On December 30, 2019, one of the Company’s three permitted mobile skins commenced operations in Indiana, thereby beginning the annual revenue guarantee related to that particular skin.

The USA based company Full House Resorts moved with change of 1.88% to $1.09 with the total traded volume of 208077 shares in recent session versus to an average volume of 113.96K. The stock was observed in the 5 days activity at -51.77%. The one month performance of stock was -68.04%. FLL’s shares are at -68.31% for the quarter and driving a -48.83% return over the course of the past year and is now at -67.46% since this point in 2018.  Right now the stock beta is 1. The average volatility for the week and month was at 28.05% and 12.52% respectively. There are 43.74M shares outstanding and 23.98M shares are floated in market.

Notable Stock News to Watch: LogMeIn (NASDAQ:LOGM)

LogMeIn (NASDAQ:LOGM) spotted trading -6.23% off 52-week high price. On the other end, the stock has been noted 30.97% away from the low price over the last 52-weeks. The stock changed 0.91% to recent value of $81.23. The stock transacted 1150979 shares during most recent day however it has an average volume of 977.38K shares. The company has 50.31M of outstanding shares and 47.59M shares were floated in the market.

On March 12, 2020, LogMeIn (NASDAQ:LOGM) a leading provider of cloud-based connectivity,  announced that its stockholders voted to adopt the previously released definitive agreement in which LogMeIn will be acquired in a transaction led by Francisco Partners, a leading technology-focused global private equity firm, and Evergreen Coast Capital Corporation, the private equity affiliate of Elliott Management Corporation, at its special meeting of stockholders held earlier .  At the special meeting, LogMeIn stockholders adopted the merger agreement with more than 74% of the outstanding shares voting in favor of the merger.  The proposed merger is expected to close in mid-2020, subject to customary closing conditions, including the receipt of regulatory approvals.

About LogMeIn

LogMeIn (NASDAQ: LOGM) simplifies how people connect with each other and the world around them to drive meaningful interactions, deepen relationships, and create better outcomes for individuals and businesses. One of the world’s top 10 public SaaS companies, and a market leader in unified communications and collaboration, identity and access management, and customer engagement and support solutions, LogMeIn has millions of customers spanning virtually every country across the globe. LogMeIn is headquartered in Boston, Massachusetts with additional locations in North America, South America, Europe, Asia and Australia.

Its earnings per share (EPS) expected to touch remained -121.50% for this year while earning per share for the next 5-years is expected to reach at 2.20%. LOGM has a gross margin of 74.30% and an operating margin of -0.10% while its profit margin remained -1.20% for the last 12 months.

According to the most recent quarter its current ratio was 0.5 that represents company’s ability to meet its current financial obligations. The price moved ahead of -4.01% from the mean of 20 days, -4.89% from mean of 50 days SMA and performed 7.15% from mean of 200 days price. Company’s performance for the week was -3.55%, -5.05% for month and YTD performance remained -5.26%.